dipyridamole has been researched along with morphine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Calignano, A; Mancuso, F; Persico, P; Sorrentino, L | 1 |
| Kisin, IE | 1 |
| Hughes, J; Vane, JR | 1 |
| Irikura, T; Iwaki, R | 1 |
| Nikfar, S; Zarrindast, MR | 1 |
| Sawynok, J; Sweeney, MI; White, TD | 1 |
| Eisenach, JC; Lavand'homme, PM | 1 |
| Eisenach, JC; Li, X; Sandner-Kiesling, A | 1 |
| Christie, MJ; Hack, SP; Vaughan, CW | 1 |
| Capasso, A; Gallo, C | 1 |
2 review(s) available for dipyridamole and morphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Effect of pharmacological substances on the blood supply and work of the heart].
Topics: Animals; Antithyroid Agents; Blood Flow Velocity; Coronary Disease; Coronary Vessels; Dipyridamole; Ganglionic Blockers; Heart; Morphine; Myocardium; Nitroglycerin; Oxygen; Papaverine; Partial Pressure; Phenothiazines; Prenylamine; Propranolol; Reserpine; Sympatholytics; Vasodilator Agents; Veins | 1969 |
12 other study(ies) available for dipyridamole and morphine
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Adenosine release in morphine-induced hypotension in rats.
Topics: 2-Chloroadenosine; Adenosine; Animals; Arginine; Blood Pressure; Dipyridamole; Hypotension; Injections, Intraperitoneal; Injections, Intravenous; Male; Morphine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Tetrabenazine; Theophylline | 1992 |
Relaxations of the isolated portal vein of the rabbit induced by nicotine and electrical stimulation.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Dipyridamole; Electric Stimulation; Hexamethonium Compounds; In Vitro Techniques; Morphine; Nicotine; Norepinephrine; Portal Vein; Prostaglandins; Rabbits; Reserpine; Scopolamine; Tetrodotoxin; Veratrine | 1970 |
[Application of unanesthesia hypoxemia tests for experimental animals on screening method of angina pectoris therapeutics].
Topics: Adenosine Triphosphate; Angina Pectoris; Animals; Atropine; Carbon Dioxide; Cardanolides; Dipyridamole; Male; Meprobamate; Methods; Morphine; Nitroglycerin; Noscapine; Oxygen; Papaverine; Propranolol; Rabbits; Rats; Technology, Pharmaceutical; Tolazoline; Vasodilator Agents | 1968 |
Different influences of adenosine receptor agonists and antagonists on morphine antinociception in mice.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dipyridamole; Dose-Response Relationship, Drug; Male; Mice; Morphine; Nociceptors; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P1; Receptors, Purinergic P2; Tail; Theophylline | 1994 |
Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine.
Topics: Adenosine; Animals; Capsaicin; Dipyridamole; In Vitro Techniques; Male; Morphine; Norepinephrine; Nucleosides; Potassium; Rats; Rats, Sprague-Dawley; Serotonin; Spinal Cord; Synaptosomes; Thioinosine | 1993 |
Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain.
Topics: Adenosine; Analgesics, Opioid; Animals; Deoxyadenosines; Dipyridamole; Drug Synergism; Injections, Spinal; Ligation; Male; Morphine; Neuritis; Pain; Pain Measurement; Physical Stimulation; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Spinal Nerves | 1999 |
Morphine-induced spinal release of adenosine is reduced in neuropathic rats.
Topics: Adenosine; Analgesics, Opioid; Animals; Behavior, Animal; Dipyridamole; Dose-Response Relationship, Drug; Hyperalgesia; Male; Morphine; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves; Synaptosomes; Vasodilator Agents | 2001 |
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |